9041099

Source:http://linkedlifedata.com/resource/pubmed/id/9041099

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001128, umls-concept:C0042105, umls-concept:C0205225, umls-concept:C0454788, umls-concept:C0566602, umls-concept:C1077578, umls-concept:C1257890, umls-concept:C2603343
pubmed:issue	10
pubmed:dateCreated	1997-3-6
pubmed:abstractText	There is no satisfactory medical therapy for patients with primary sclerosing cholangitis. Ursodiol (ursodeoxycholic acid) benefits patients with primary biliary cirrhosis, another cholestatic liver disease.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/9041099-9041105
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Ursodeoxycholic Acid
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0028-4793
pubmed:author	pubmed-author:LindorK DKD
pubmed:issnType	Print
pubmed:day	6
pubmed:volume	336
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	691-5
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9041099-Adult, pubmed-meshheading:9041099-Cholangitis, Sclerosing, pubmed-meshheading:9041099-Disease-Free Survival, pubmed-meshheading:9041099-Double-Blind Method, pubmed-meshheading:9041099-Female, pubmed-meshheading:9041099-Follow-Up Studies, pubmed-meshheading:9041099-Humans, pubmed-meshheading:9041099-Male, pubmed-meshheading:9041099-Time Factors, pubmed-meshheading:9041099-Treatment Failure, pubmed-meshheading:9041099-Ursodeoxycholic Acid
pubmed:year	1997
pubmed:articleTitle	Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group.
pubmed:affiliation	Mayo Foundation, Rochester, MN 55905, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study